Method and system for called party to provide indication information to calling party
    71.
    发明授权
    Method and system for called party to provide indication information to calling party 有权
    被叫方向主叫方提供指示信息的方法和系统

    公开(公告)号:US07974403B2

    公开(公告)日:2011-07-05

    申请号:US11505108

    申请日:2006-08-15

    IPC分类号: H04M1/00

    摘要: The present invention discloses a method for a called party to provide indication information for a calling party. The method includes the steps of: presetting the indication information to be provided to the calling party at the called party; before the called party answers the call in the connection procedure between the calling party and the called party, the network side obtaining the preset indication information from the called party and sending the indication information to the calling party. Accordingly, the present invention discloses a system for a called party to provide the indication information to a calling party. The present invention makes it possible that the called party flexibly selects the indication information to be provided to the calling party and the problem that only the indication information in the indication information database can be provided is avoided.

    摘要翻译: 本发明公开了一种被叫方为主叫方提供指示信息的方法。 该方法包括以下步骤:在被叫方预置提供给主叫方的指示信息; 在被叫方在主叫方与被叫方之间的连接过程中应答呼叫时,网络侧从被叫方获取预设指示信息,并向主叫方发送指示信息。 因此,本发明公开了一种被叫方向主叫方提供指示信息的系统。 本发明使得被叫方能够灵活地选择要提供给主叫方的指示信息,并且避免了只能提供指示信息数据库中的指示信息的问题。

    Method for production of alkali metal chromates
    72.
    发明授权
    Method for production of alkali metal chromates 有权
    碱金属铬酸盐的生产方法

    公开(公告)号:US07968066B2

    公开(公告)日:2011-06-28

    申请号:US10549594

    申请日:2003-03-19

    IPC分类号: C01G37/14

    CPC分类号: C01G37/14

    摘要: This invention relates to a method for producing chromates, especially for producing alkali metal chromates. The method comprises following steps: the obtaining of a mixture of alkali metal hydroxide, alkali metal chromate, and ferrous residue after the reaction of chromite ore with an oxidant in the reactor in the presence of molten salt or in aqueous solution of alkali metal hydroxide, the obtaining of a leaching slurry by leaching the reaction products with aqueous solution of alkali metal hydroxide, the separating of the primary chromate product from the leaching slurry, the obtaining of pure chromate crystal by purifying the primary chromate product. Both the primary chromate product and the pure chromate crystal can be used as the raw materials to manufacture other chromium compounds. Compared with the currently-used roasting method, the method has the advantages of decreasing the reaction temperature by about 700° C., of improving the chromium recovery rate up to nearly 100%, of minimizing the amount of the ferrous residue by not adding calcium-containing auxiliaries, and of completely eliminating the disposal problem of the chromium-containing residue and the environmental pollution due to the addition of calcium-containing auxiliaries, by using ferrous residue as the raw materials for other industries after extraction of magnesium.

    摘要翻译: 本发明涉及生产铬酸盐的方法,特别是生产碱金属铬酸盐。 该方法包括以下步骤:在熔融盐存在下或在碱金属氢氧化物的水溶液中,在铬酸铁矿与氧化剂反应后,获得碱金属氢氧化物,碱金属铬酸盐和亚铁残留物的混合物, 通过将碱金属氢氧化物水溶液浸出反应产物,从浸出浆中分离出一次铬酸盐产物,通过纯化一次铬酸盐产物得到纯的铬酸盐晶体,从而获得浸出浆料。 主要的铬酸盐产物和纯铬酸盐晶体都可以用作制造其他铬化合物的原料。 与目前使用的焙烧方法相比,该方法具有将反应温度降低约700℃,将铬回收率提高至近100%的优点,通过不添加钙来最小化亚铁残留量 并且完全消除了含铬残渣的处理问题,以及由于添加含钙助剂而导致的环境污染,在提取镁后,以铁渣作为其他工业的原料。

    METHOD AND APPARATUS FOR CARDIAC PROTECTION PACING
    73.
    发明申请
    METHOD AND APPARATUS FOR CARDIAC PROTECTION PACING 有权
    心脏保护剂的方法和装置

    公开(公告)号:US20110144709A1

    公开(公告)日:2011-06-16

    申请号:US13029631

    申请日:2011-02-17

    IPC分类号: A61N1/365

    摘要: A pacing system delivers cardiac protection pacing to protect the heart from injuries associated with ischemic events. The pacing system detects an ischemic event and, in response, initiates one or more cardiac protection pacing sequences each including alternative pacing and non-pacing periods. In one embodiment, the pacing system initiates cardiac protection pacing sequences including at least one postconditioning sequence to protect the heart from a detected ischemic event and a plurality prophylactic preconditioning sequences to protect the heart from probable future ischemic events.

    摘要翻译: 起搏系统提供心脏保护起搏,以保护心脏免受与缺血事件相关的损伤。 起搏系统检测缺血事件,并作为响应启动一个或多个心脏保护起搏序列,每个起搏序列包括替代起搏和非起搏期。 在一个实施例中,起搏系统启动心脏保护起搏序列,包括至少一个后处理序列以保护心脏免受所检测的缺血事件和多个预防性预处理序列,以保护心脏免受可能的未来缺血事件。

    RICE NON-ENDOSPERM TISSUE EXPRESSION PROMOTER (OSTSP 1) AND THE USE THEREOF
    74.
    发明申请
    RICE NON-ENDOSPERM TISSUE EXPRESSION PROMOTER (OSTSP 1) AND THE USE THEREOF 审中-公开
    非特异性非特异性组织表达促进剂(OSTSP 1)及其用途

    公开(公告)号:US20110119794A1

    公开(公告)日:2011-05-19

    申请号:US12741226

    申请日:2008-11-19

    CPC分类号: C12N15/8223

    摘要: An isolated rice non-endosperm tissue expression promoter, OsTSP I, and the use thereof. The promoter comprises the defined sequence of 1785 by (SEQ ID NO: 1), given in the specification, or its fragment or variant, or a nucleotide sequence If which hybridizes to SEQ ID NO: 1, or its fragment or variant, under stringent conditions. The activity of OsTSP I is comfirmed by transgenic methods. As determined histochemically, OsTSP I reglulates GUS expression in a tissue-specific manner and is not active in endosperm tissues. The OsTSP I can be used as a powerful tool for the investigation and control of gene expression in rice and other crops. It is particularly advantageous for development of safe transgenic foods such as rice.

    摘要翻译: 分离的水稻非胚乳组织表达启动子OsTSP I及其用途。 启动子包括在说明书中给出的(SEQ ID NO:1)所定义的序列1785或其片段或变体,或在严格条件下与SEQ ID NO:1或其片段或变体杂交的核苷酸序列 条件。 OsTSP I的活性由转基因方法证实。 按组织学方法测定,OsTSP I以组织特异性方式调节GUS表达,并且在胚乳组织中不起作用。 OsTSP可作为水稻和其他作物基因表达调查和控制的有力工具。 特别有利于开发安全的转基因食品如水稻。

    Automatic orientation determination for ECG measurements using multiple electrodes
    75.
    发明授权
    Automatic orientation determination for ECG measurements using multiple electrodes 有权
    使用多个电极的ECG测量的自动取向确定

    公开(公告)号:US07941206B2

    公开(公告)日:2011-05-10

    申请号:US12694833

    申请日:2010-01-27

    IPC分类号: A61B5/04

    摘要: Cardiac monitoring and/or stimulation methods and systems provide monitoring, defibrillation and/or pacing therapies. A signal processor receives a plurality of composite signals associated with a plurality of sources, separates a signal using a source separation algorithm, and identifies a cardiac signal using a selected vector. The signal processor may iteratively separate signals from the plurality of composite signals until the cardiac signal is identified. The selected vector may be updated if desired or necessary. A method of signal separation involves detecting a plurality of composite signals at a plurality of locations, separating a signal using source separation, and selecting a vector that provides a cardiac signal. The separation may include a principal component analysis and/or an independent component analysis. Vectors may be selected and updated based on changes of position and/or orientation of implanted components and changes in patient parameters such as patient condition, cardiac signal-to-noise ratio, and disease progression.

    摘要翻译: 心脏监测和/或刺激方法和系统提供监测,除颤和/或起搏治疗。 信号处理器接收与多个源相关联的多个复合信号,使用源分离算法分离信号,并使用所选择的向量来识别心脏信号。 信号处理器可以迭代地分离来自多个复合信号的信号,直到识别出心脏信号。 如果需要或必要,可以更新所选择的向量。 信号分离的方法包括在多个位置检测多个复合信号,使用源分离分离信号,以及选择提供心脏信号的向量。 分离可以包括主成分分析和/或独立成分分析。 可以基于植入组件的位置和/或取向的改变以及患者参数(例如患者状况,心脏信噪比和疾病进展)的变化来选择和更新载体。

    Arrhythmia discrimination using electrocardiograms sensed from multiple implanted electrodes
    77.
    发明授权
    Arrhythmia discrimination using electrocardiograms sensed from multiple implanted electrodes 有权
    使用从多个植入电极感测的心电图的心律失常辨别

    公开(公告)号:US07917196B2

    公开(公告)日:2011-03-29

    申请号:US11125020

    申请日:2005-05-09

    IPC分类号: A61B5/0464

    CPC分类号: A61B5/04011 A61B5/7203

    摘要: Cardiac monitoring and/or stimulation methods and systems provide for monitoring, diagnosing, defibrillation and pacing therapies, or a combination of these capabilities, including cardiac systems incorporating or cooperating with neuro-stimulating devices, drug pumps, or other therapies. Embodiments relate generally to implantable medical devices employing automated cardiac activation sequence monitoring and/or tracking for arrhythmia discrimination. Embodiments are directed to devices and methods involving sensing a plurality of composite cardiac signals using a plurality of implantable electrodes. A source separation is performed using the sensed plurality of composite cardiac signals and the separation produces one or more cardiac signal vectors associated with one or more cardiac activation sequences that is indicative of ischemia. A change of the one or more cardiac signal vectors is detected using the one or more cardiac signal vectors. Cardiac arrhythmias are discriminated using the one or more cardiac signal vectors.

    摘要翻译: 心脏监测和/或刺激方法和系统提供监测,诊断,除颤和起搏治疗,或这些能力的组合,包括结合或与神经刺激装置,药物泵或其他疗法组合的心脏系统。 实施例一般涉及使用自动心脏激活序列监测和/或跟踪用于心律失常鉴别的可植入医疗装置。 实施例涉及使用多个可植入电极感测多个复合心脏信号的装置和方法。 使用感测的多个复合心脏信号进行源分离,并且分离产生与指示缺血的一个或多个心脏激活序列相关联的一个或多个心脏信号载体。 使用一个或多个心脏信号矢量检测一个或多个心脏信号矢量的改变。 使用一个或多个心脏信号载体来区分心律失常。

    ECG signal power vector detection of ischemia or infarction
    78.
    发明授权
    ECG signal power vector detection of ischemia or infarction 有权
    心电信号功率矢量检测缺血或梗塞

    公开(公告)号:US07894889B2

    公开(公告)日:2011-02-22

    申请号:US12484061

    申请日:2009-06-12

    申请人: Yi Zhang

    发明人: Yi Zhang

    IPC分类号: A61B5/0452

    摘要: A method comprising sensing at least one cardiac signal representative of cardiac activity of a subject using an implantable medical device (IMD), calculating, from the cardiac signal, a first dominant vector corresponding to a direction and magnitude of maximum signal power of an ST-T first segment of a cardiac cycle and a second dominant vector corresponding to a direction and magnitude of maximum signal power of a P-QRS second segment of a cardiac cycle, measuring a change in the first dominant vector, measuring a change in the second dominant vector, and subtracting the change in the second dominant vector from the measured change in the first dominant vector to form a difference.

    摘要翻译: 一种方法,包括使用可植入医疗装置(IMD)感测表示对象的心脏活动的至少一个心脏信号,从心脏信号计算对应于ST段的最大信号功率的方向和幅度的第一显性矢量, T心脏周期的第一段和对应于心动周期的P-QRS第二段的最大信号功率的方向和幅度的第二主要矢量,测量第一显性矢量的变化,测量第二主要变化 向量,并从第一显性向量的测量变化中减去第二显性向量中的变化以形成差。